Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8444)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 18, 2017 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tarao K, Tanaka K, Nozaki A, Sato A, Ishii T, Komatsu H, Ikeda T, Komatsu T, Matsushima S, Oshige K. Efficacy and safety of dual therapy with daclatasvir and asunaprevir in elderly patients. World J Hepatol 2017; 9(11): 544-550 [PMID: 28469810 DOI: 10.4254/wjh.v9.i11.544] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v9/i11/544.htm |
| Number | Citing Articles |
| 1 |
Shimaa Kamel, Hagar Elessawy, Ossama Ashraf, Ahmed Elbaz, Hany Dabbous, Manal El-Sayed, Safaa Ali, Heba Kamel. Effectiveness of Direct-Acting Antivirals in Treatment of Elderly Egyptian Chronic Hepatitis C Patients. Gastroenterology Insights 2021; 12(3): 336 doi: 10.3390/gastroent12030031
|
| 2 |
F. Ji, B. Wei, Y. H. Yeo, E. Ogawa, B. Zou, C. D. Stave, Z. Li, S. Dang, N. Furusyo, R. C. Cheung, M. H. Nguyen. Systematic review with meta‐analysis: effectiveness and tolerability of interferon‐free direct‐acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia. Alimentary Pharmacology & Therapeutics 2018; 47(5): 550 doi: 10.1111/apt.14507
|
| 3 |
Fumitaka Suzuki, Naoya Hatanaka, Etsuya Bando, Koji Nakamura, Akira Komoto. Safety and effectiveness of daclatasvir and asunaprevir dual therapy in patients with genotype 1 chronic hepatitis C: results from postmarketing surveillance in Japan. Hepatology International 2018; 12(3): 244 doi: 10.1007/s12072-018-9872-z
|
| 4 |
Rosanna Villani, Matteo Monami, Francesca Di Cosimo, Gilda Fioravanti, Edoardo Mannucci, Gianluigi Vendemiale, Gaetano Serviddio. Direct‐acting antivirals for HCV treatment in older patients: A systematic review and meta‐analysis. Journal of Viral Hepatitis 2019; 26(11): 1249 doi: 10.1111/jvh.13169
|
| 5 |
Jieun Lee, Sang Bong Ahn, Sun Young Yim, Jihyun An, Dae Won Jun, Min Jung Ko, Dong Ah Park, Jeong‐Ju Yoo. Efficacy and safety of direct‐acting antiviral therapy for hepatitis C virus in elderly patients (≥65 years old): A systematic review and meta‐analysis. Journal of Viral Hepatitis 2022; 29(7): 496 doi: 10.1111/jvh.13679
|
| 6 |
Efficacy and Safety of Daclatasvir and Asunaprevir Combination Therapy in Elderly Chronic Hepatitis C Patients. Journal of Korean Society of Health-System Pharmacists 2018; 35(4): 453 doi: 10.32429/jkshp.2018.35.4.007
|
| 7 |
Yoshinori Ozono, Kenji Nagata, Satoru Hasuike, Hisayoshi Iwakiri, Kenichi Nakamura, Mai Tsuchimochi, Yuri Yamada, Yuka Takaishi, Mitsue Sueta, Tadashi Miike, Yoshihiro Tahara, Shojiro Yamamoto, Kotaro Shide, Tomonori Hidaka, Yoko Kubuki, Kazunori Kusumoto, Toshimasa Ochiai, Junya Kato, Naoto Komada, Shuichi Hirono, Kazuo Kuroki, Masafumi Shigehira, Kazuya Shimoda. Efficacy and safety of sofosbuvir and ledipasvir in Japanese patients aged 75 years or over with hepatitis C genotype 1. World Journal of Hepatology 2017; 9(36): 1340-1345 doi: 10.4254/wjh.v9.i36.1340
|
| 8 |
Tanner Wright, Yalong Wang, Mark T. Bedford. The Role of the PRMT5–SND1 Axis in Hepatocellular Carcinoma. Epigenomes 2021; 5(1): 2 doi: 10.3390/epigenomes5010002
|